Lung cancer, or bronchogenic carcinoma, is the collective name for cancers that start in the lungs— usually in the airways (bronchi or bronchioles) or small air sacs (alveoli). Lung cancer is known for its aggressive nature and high mortality rate. read more about What Black Americans Need to Know Clinical Trials for Lung Cancer
Lupus continues to affect racial and ethnic minority groups at disproportionately high rates, yet these same communities remain significantly underrepresented in clinical trials. Recognizing this critical gap, Lupus Therapeutics, through its Lupus Clinical Investigators Network (LuCIN), is leading research on read more about How Social Media and AI Are Transforming Clinical Trial Recruitment
Gene therapy may restore vision to children and adults robbed of their sight by a rare inherited condition called Leber congenital amaurosis, researchers report. The illness is caused by mutations in the GUCY2D gene, which is critical to producing proteins read more about This Clinical Trial Reversed a Rare Cause of Vision Loss
Despite the challenges of living with diabetes, a new AI-driven detection tool can help ease the burden of the disease. Researchers from Johns Hopkins Medicine and the University of Wisconsin-Madison have published a study on the use of autonomous artificial read more about This AI Tool Detects Diabetic Eye Disease Faster in Black Americans
The Lupus Research Alliance (LRA), which formed and administers the Lupus Accelerating Breakthroughs Consortium (Lupus ABC)—a public-private partnership with the U.S. Food and Drug Administration (FDA)—is leading efforts to ensure that the voices of people living with lupus are central read more about How Patients Are Driving Breakthroughs in Lupus Research
